Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply

被引：0
|
作者：
Giada Crescioli
Cecilia Lanzi
Guido Mannaioni
Alfredo Vannacci
Niccolò Lombardi
机构：
[1] University of Florence,Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology
[2] Tuscan Regional Centre of Pharmacovigilance,Toxicology Unit and Poison Centre
[3] Careggi University Hospital,undefined
来源：
Internal and Emergency Medicine | 2021年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：799 / 800
页数：1
相关论文
共 50 条
  • [1] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions-reply
    Crescioli, Giada
    Lanzi, Cecilia
    Mannaioni, Guido
    Vannacci, Alfredo
    Lombardi, Niccolo
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 799 - 800
  • [2] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
    Giada Crescioli
    Valentina Brilli
    Cecilia Lanzi
    Andrea Burgalassi
    Alessandra Ieri
    Roberto Bonaiuti
    Elias Romano
    Rinaldo Innocenti
    Guido Mannaioni
    Alfredo Vannacci
    Niccolò Lombardi
    [J]. Internal and Emergency Medicine, 2021, 16 : 697 - 710
  • [3] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions
    Crescioli, Giada
    Brilli, Valentina
    Lanzi, Cecilia
    Burgalassi, Andrea
    Ieri, Alessandra
    Bonaiuti, Roberto
    Romano, Elias
    Innocenti, Rinaldo
    Mannaioni, Guido
    Vannacci, Alfredo
    Lombardi, Niccolo
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 697 - 710
  • [4] Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
    Alfredo Jose Pardo-Cabello
    Victoria Manzano-Gamero
    Susana Belda-Rustarazo
    Pilar Giner-Escobar
    [J]. Internal and Emergency Medicine, 2021, 16 : 797 - 798
  • [5] Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug-drug interactions-comment
    Pardo-Cabello, Alfredo Jose
    Manzano-Gamero, Victoria
    Belda-Rustarazo, Susana
    Giner-Escobar, Pilar
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 797 - 798
  • [6] Cutaneous adverse drug reactions in hospitalised patients
    Lee, H. Y.
    Tay, L. K.
    Thirumoorthy, T.
    Pang, S. M.
    [J]. SINGAPORE MEDICAL JOURNAL, 2010, 51 (10) : 767 - 774
  • [7] Drug-Drug Interactions - Induced Adverse Drug Reactions in Hospitalized Patients
    Ponte, M.
    Serra, H.
    Wachs, A.
    [J]. DRUG SAFETY, 2012, 35 (10) : 882 - 882
  • [8] Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions
    Verbic, Matej Dobravc
    Brvar, Miran
    Kos, Mojca Kerec
    [J]. ACTA PHARMACEUTICA, 2023, 73 (02) : 195 - 210
  • [9] Adverse Cutaneous Drug Reactions - Case Series
    Sukanya, M.
    Srinivasan, Shreya
    Sanjay, Nehete Sanket
    Kumar, Ashok N.
    [J]. JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (05): : 32 - 35
  • [10] Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2
    Yalcin, Nadir
    Demirkan, Kutay
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2023, 108 (10)
12345